239 related articles for article (PubMed ID: 1386207)
1. Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases.
Forno LS
Ann N Y Acad Sci; 1992 May; 648():6-16. PubMed ID: 1386207
[TBL] [Abstract][Full Text] [Related]
2. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.
Davis MY; Keene CD; Jayadev S; Bird T
J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863
[TBL] [Abstract][Full Text] [Related]
3. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
Whitehouse PJ; Kellar KJ
J Neural Transm Suppl; 1987; 24():175-82. PubMed ID: 2960781
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
[TBL] [Abstract][Full Text] [Related]
6. Animal models of neurodegenerative diseases.
Ribeiro FM; Camargos ER; de Souza LC; Teixeira AL
Braz J Psychiatry; 2013; 35 Suppl 2():S82-91. PubMed ID: 24271230
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
Grafe MR; Forno LS; Eng LF
J Neuropathol Exp Neurol; 1985 Jan; 44(1):47-59. PubMed ID: 2578185
[TBL] [Abstract][Full Text] [Related]
8. Associations of Alzheimer's Disease Neuropathologic Changes with Clinical Presentations of Parkinson's Disease.
Tong Q; Chen L
J Alzheimers Dis; 2021; 81(1):201-207. PubMed ID: 33720903
[TBL] [Abstract][Full Text] [Related]
9. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
10. Transgenic animal models of neurodegeneration based on human genetic studies.
Harvey BK; Richie CT; Hoffer BJ; Airavaara M
J Neural Transm (Vienna); 2011 Jan; 118(1):27-45. PubMed ID: 20931247
[TBL] [Abstract][Full Text] [Related]
11. Dementia of the Alzheimer's type and Huntington's disease.
Reyes MG; Gibbons S
Neurology; 1985 Feb; 35(2):273-7. PubMed ID: 3155827
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol metabolism and homeostasis in the brain.
Zhang J; Liu Q
Protein Cell; 2015 Apr; 6(4):254-64. PubMed ID: 25682154
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Mitochondrial Complex II and III Activity in Brain Sections: A Histoenzymological Technique.
Roy R; Paul R; Bhattacharya P; Borah A
Methods Mol Biol; 2022; 2497():73-81. PubMed ID: 35771435
[TBL] [Abstract][Full Text] [Related]
14. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal MF
Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
[TBL] [Abstract][Full Text] [Related]
15. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.
Ditter SM; Mirra SS
Neurology; 1987 May; 37(5):754-60. PubMed ID: 3033544
[TBL] [Abstract][Full Text] [Related]
16. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease.
Hulette C; Mirra S; Wilkinson W; Heyman A; Fillenbaum G; Clark C
Neurology; 1995 Nov; 45(11):1991-5. PubMed ID: 7501147
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
Hroudová J; Singh N; Fišar Z
Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
[TBL] [Abstract][Full Text] [Related]
18. Dementia in movement disorders.
Teräväinen H; Hietanen M; Stoessl J; Calne DB
Can J Neurol Sci; 1986 Nov; 13(4 Suppl):546-58. PubMed ID: 2947669
[TBL] [Abstract][Full Text] [Related]
19. Involvement of molecular chaperone in protein-misfolding brain diseases.
Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Behl T; Abdellatif AAH; Bhaskaran PM; Dachani SR; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Dailah HG; Bhatia S; Al-Harrasi A; Bungau S
Biomed Pharmacother; 2022 Mar; 147():112647. PubMed ID: 35149361
[TBL] [Abstract][Full Text] [Related]
20. Neurolinguistic features of spontaneous language production dissociate three forms of neurodegenerative disease: Alzheimer's, Huntington's, and Parkinson's.
Illes J
Brain Lang; 1989 Nov; 37(4):628-42. PubMed ID: 2479447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
